An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * New OTC Weight Loss Pill Granted Patent On May 6, Olfactive Biosolutions was granted a patent for formulations of food molecules that cause significant weight loss when taken as a daily pill. The company’s Pivit supplement induces the simultaneous secretion of...
Testosterone Before Birth: A Key Factor in Childhood Body Composition
What goes on in the womb does not stay in the womb as prenatal hormone exposure plays a critical role in shaping childhood growth and body composition. A recent study published in The Journal of Clinical Endocrinology & Metabolism suggests that prenatal testosterone exposure is linked to sex-specific body composition changes, with boys exposed to...
AI-Driven Analysis Highlights Diabetes Severity Risk in Black Communities
A new study in The Journal of Clinical Endocrinology & Metabolism has revealed that Black/African Americans are significantly more likely to develop severe insulin-deficient diabetes (SIDD), a more serious form of the disease, compared to White Americans. Using data-driven cluster analysis, a technique widely used within the field of artificial intelligence (AI) and Machine Learning,...
Marrow Fat Not a Reliable Marker for Fragility Fracture Risk in Postmenopausal Women
A new study has found that bone marrow fat content, as measured by advanced imaging techniques, does not predict the risk of fractures in postmenopausal women. The findings, recently published in The Journal of the Endocrine Society, challenge the idea that bone marrow adipose tissue (BMAT) plays a significant role in fracture susceptibility and suggest...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * First Participant Dosed in Pivotal Phase 3 LUCIDITY Trial of Avexitide in Post-Bariatric Hypoglycemia On April 30, Amylyx Pharmaceuticals, Inc. announced that the first participant has been dosed in the pivotal Phase 3 LUCIDITY clinical trial of avexitide, an investigational, first-in-class glucagon-like...
Endocrine Society is Advocating for You We know this has been an extraordinary turbulent and disruptive time for U.S. researchers and our colleagues around the world. Since January, there have been a myriad of U.S. executive actions affecting researchers, including cuts to research, firing of federal workers, rescinded grants, and withdrawn funding opportunities. In early...
We Urge U.S. Lawmakers to Restore NIH Funding and Diabetes Prevention Program Let’s not sugar coat the situation: Biomedical research funding in the United States has taken a significant hit in recent months. Deep budget cuts and staff layoffs at the National Institutes of Health (NIH) threaten not only the livelihoods of our many research... A Game-Changer in Osteoporosis and Fracture Prevention On behalf of Endocrine Society’s Bone and Mineral Special Interest Group Steering Committee, Vafa Tabatabaie, MD, and Muriel Babey, MD, discuss the importance of fracture liaison services, how they can contribute to an improved quality of life for the patients as well as cost savings for the facility,...
